Cambridge Capital Group: Investment Portfolio & Startup News

Cambridge Capital Group

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Fuse Diagnostics raises £1m in funding led by The FSE Group for instrument-free tests that detect pathogens outside the laboratory

15 Sept 2026

Fuse Diagnostics raises £1m in funding led by The FSE Group for instrument-free tests that detect pathogens outside the laboratory

Fuse Diagnostics develops rapid molecular diagnostic tests that detect pathogens and contaminants without specialist laboratory infrastructure. Its Flip platform pairs proprietary amplification technology with a low cost, disposable test design, giving industrial and research teams laboratory-quality results in the environments where testing is actually needed.

Semarion

31 Mar 2026

Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery

Semarion develops cell assay technology that enables adherent cell models to be handled as assay-ready, barcoded reagents. Its platform is used by pharmaceutical and life sciences organisations to improve flexibility, scalability and data generation in drug discovery workflows.

Cambridge Capital Group

Investment Portfolio

Fuse Diagnostics raises £1m in funding led by The FSE Group for instrument-free tests that detect pathogens outside the laboratory

Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery

More venture news

Zenithon raises a £7.5m seed round led by BACKED for ML models that solves complex physics

Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training

Something & Nothing unlocks £5m in funding led by Venrex for premium soft drinks built on flavour